The Online Investor

Slideshow IPOs

By The Online Investor Staff, updated Tue., Oct. 15, 11:39 PM

Slide #1. Vir Biotechnology, Inc. Initial Public Offering

Company: Vir Biotechnology, Inc.
Proposed Symbol: VIR
Shares Offered: 7,142,858
Price Per Share: $20.00
Over-Allotment: 1,071,428
Description: Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, announced today that it has priced its initial public offering of 7,142,858 shares of its common stock at a public offering price of $20.00 per share. The gross proceeds to Vir, before deducting underwriting discounts, commissions and offering expenses, is expected to be approximately $142.9 million. All of the common stock is being offered by Vir. In addition, Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.

IPOs: Vir Biotechnology, Inc.

List of IPOs in this Slideshow: Company Ticker IPO Date Thunder Bridge Acquisition II, Ltd. THBRU 9F Inc. JFU SmileDirectClub, Inc. SDC Experience Investment Corp. EXPCU SpringWorks Therapeutics, Inc. SWTX Satsuma Pharmaceuticals, Inc. STSA Apex Technology Acquisition Corporation APXTU Envista Holdings Corporation NVST Peloton Interactive, Inc. PTON Oportun Financial Corporation OPRT Viela Bio, Inc. VIE Aprea Therapeutics, Inc. APRE MetroCity Bankshares, Inc. MCBS HBT Financial, Inc. HBT Vir Biotechnology, Inc. VIR

IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.